HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ON09310

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - ON09310: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - ON09310: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - ON09310: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - ON09310: 1

Experts

1.	He, Q: 1 article (04/2008)
2.	Huang, Y: 1 article (04/2008)
3.	Jin, W: 1 article (04/2008)
4.	Luo, X: 1 article (04/2008)
5.	Reddy, E P: 1 article (04/2008)
6.	Reddy, M V R: 1 article (04/2008)
7.	Sheikh, M S: 1 article (04/2008)

Related Diseases

1.	Neoplasms (Cancer) 04/17/2008 - "Here we report that COX-2-selective celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 (DR5) and cooperate with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the ligand for DR5, to induce apoptosis in COX-2-positive and -negative cancer cells. "

Related Drugs and Biologics

1.	TNF-Related Apoptosis-Inducing Ligand Receptors
2.	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
3.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4.	Ligands
5.	Celecoxib (Celebrex)